3,3',5,5'-tetramethylbenzidine has been researched along with thiourea in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Filimonov, AS; Filimonova, MV; Makarchuk, VM; Podosinnikova, TS; Samsonova, AS; Shevchenko, LI | 1 |
Filimonov, A; Filimonova, M; Ivanov, S; Kaprin, A; Koryakin, S; Makarchuk, V; Saburov, V; Saburova, A; Sevankaeva, L; Shegay, P; Shevchenko, L; Surinova, V; Yakovleva, N; Yuzhakov, V | 1 |
Filimonov, AS; Filimonova, MV; Ivanov, SA; Izmestieva, OS; Kaprin, AD; Lychagin, AA; Makarchuk, VM; Saburov, VO; Saburova, AS; Shegay, PV; Shevchenko, LI; Surinova, VI | 1 |
3 other study(ies) available for 3,3',5,5'-tetramethylbenzidine and thiourea
Article | Year |
---|---|
Comparison of Antitumor Effects of Combined and Separate Treatment with NO Synthase Inhibitor T1023 and PDK1 Inhibitor Dichloroacetate.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Dichloroacetic Acid; Female; Mice; Nitric Oxide Synthase; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Thiourea | 2019 |
The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues.
Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Gamma Rays; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Radiation Protection; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Thiourea | 2021 |
Radioprotective Activity of the Nitric Oxide Synthase Inhibitor T1023. Toxicological and Biochemical Properties, Cardiovascular and Radioprotective Effects.
Topics: Animals; Enzyme Inhibitors; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Radiation Protection; Rats; Thiourea | 2020 |